Advertisement
Organisation › Details
University of California (System)
Start | 1984-01-01 existent | |
Industry | science | |
Industry 2 | education & social services | |
City | n. a. | |
Address record changed: 2011-05-15 | ||
Basic data | Employees | n. a. |
Record changed: 2022-07-25 |
Advertisement
More documents for University of California (System)
- [1] InflaRx N.V.. (1/25/24). "Press Release: InflaRx Announces Initiation of Its Commitment Program for GOHIBIC (vilobelimab) to Help Broaden Access for Eligible Patients". Ann Arbor, MI....
- [2] Bico Group AB. (10/11/23). "Press Release: Cellink and the University of California, San Diego Partner to Open a 3D Bioprinting Centre of Excellence". San Diego, CA....
- [3] BlueRock Therapeutics LP. (8/23/23). "Press Release: BlueRock’s Phase I Study with Bemdaneprocel in Patients with Parkinson’s Disease Meets Primary Endpoint". Wuppertal....
- [4] Oxitope Pharma B.V.. (9/16/21). "Press Release: Launch of Oxitope Pharma, a Biopharmaceutical Start-up Dedicated to the Discovery and Development of Antibody-based Medicines for the Treatment of Diseases Caused by Oxidative Stress". Amsterdam....
- [5] Forbion Capital Partners. (9/16/21). "Press Release: Forbion Launches Portfolio Company Oxitope Pharma Focused on Inflammatory, Cardiovascular and Fibrotic Diseases". Naarden....
- [6] Thermo Fisher Scientific Inc.. (7/7/21). "Press Release: Thermo Fisher Scientific and UC Davis Launch Center of Excellence in Clinical Metabolomics". San José, CA & Davis, CA....
- [7] Priavoid GmbH. (12/9/20). "Press Release: Nobel Prize Winner Stanley Prusiner Joins Priavoid’s Supervisory Board". Düsseldorf & San Franicsco, CA....
- [8] A2 Biotherapeutics, Inc.. (10/6/20). "Press Release: A2 Biotherapeutics Closes $71.5m Series B to Begin Clinical Development of Its Potentially TransformativeSelective Tumor Cell Therapeutics". Agoura Hills, CA....
- [9] ERS Genomics Ltd.. (9/22/20). "Press Release: ERS Genomics Appoints Michael Arciero as Vice-President of Intellectual Property & Commercial Development". Dublin....
- [10] Ysios Capital. (6/10/20). "Press Release: Ysios Capital Presents Its Third Fund of € 200M". San Sebastián & Barcelona....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top